Hoyoung Huh insider trades
Open-market stock purchases and sales by Hoyoung Huh, Director, 10% Owner at Akari Therapeutics plc, from SEC Form 4 filings since Apr 21, 2010.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Oct 5, 2026 | AKTX Akari Therapeutics plc | Bought (not open market) | $48.7K |
| Aug 18, 2026 | AKTX Akari Therapeutics plc | Bought (not open market) | $136K |
| Aug 18, 2026 | AKTX Akari Therapeutics plc | Bought (not open market) | — |
| Aug 18, 2026 | AKTX Akari Therapeutics plc | Bought (not open market) | — |
| Jun 11, 2026 | PLRX Pliant Therapeutics, Inc | Bought (not open market) | — |
| Dec 16, 2025 | AKTX Akari Therapeutics plc | Bought | $250K |
| Dec 16, 2025 | AKTX Akari Therapeutics plc | Bought | $1.2M |
Companies traded
- AKTX Akari Therapeutics plc: 2 buys, last Oct 5, 2026
- PLRX Pliant Therapeutics, Inc: other filings, last Jun 11, 2026
- PKBO Peak Bio, Inc: 18 buys, last Nov 14, 2024
- EIDX Eidos Therapeutics, Inc: other filings, last Jun 22, 2018
- CTMX CytomX Therapeutics, Inc: other filings, last Jun 13, 2018
- GERN Geron Corp: other filings, last May 15, 2018
- ANTB AntriaBio, Inc: other filings, last Oct 31, 2016
- FACT Facet Biotech Corp: other filings, last Apr 21, 2010